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Abstract 
 
RNA is active in multiple biological processes, not only as an information carrier 
but in catalyzing reactions and regulating gene expression. To understand the basis for 
this versatility, it is critical to establish structure-function relationships in RNAs. 
Covalently-attached biochemical or biophysical probes (e.g., fluorophores) at site-specific 
positions are often used to uncover these correlates in target RNAs. Generation of such 
modified RNAs often requires the conjugation of molecular probes to suitable chemical 
functionalities that have been introduced at either terminal or internal positions in the 
target RNA. A simple approach to create a 5'-labeled RNA is through an in vitro 
transcription (IVT) using T7 RNA polymerase. Since IVTs of DNA templates containing a 
class III ϕ6.5 promoter by T7 RNA polymerase is preferentially initiated by GTP, guanosine 
analogs (nucleoside or nucleotide monophosphate) have been used as transcriptional 
initiators to introduce different reactive groups at the 5'-end of transcribed RNAs. 
Although adding guanosine analogs in a large molar excess over GTP at the start of 
transcription generates transcripts that are predominantly 5'-modified, the overall yield 
of RNA is seriously compromised due to the requirement for GTP during Based on the 
premise that the poor yield results from the rapid depletion of limited GTP, which was 
intentionally used at low concentrations to favor incorporation of the modified analog, 
we have investigated and validated a phased-addition strategy that results in high yields 
of full-length, 5'-modified RNAs from small-scale transcriptions. We examined this 
method using three guanosine analogs: 5'-deoxyguanosine-5'-monophosphorothioate 
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(GSMP), 5'-deoxy-5'-hydrazinylguanosine (NH2NH-G), and 5'-azido-5'deoxyguanosine (N3-
G).  
The phased-addition strategy is made up of two components that differ from a 
typical modified in vitro transcription. The first change is that a supplementation rather 
than a fixed-ratio approach is used. The former consists of supplementing GTP to the IVT 
during the first three or four hours of transcription as opposed to the fixed-ratio approach 
in which no additional GTP is added once transcription is initiated. The supplementation 
approach allows for a second change, which is to increase the initial guanosine 
analog:GTP ratio without concerns about the yield. Previously reported modified in vitro 
transcriptions using GSMP, NH2NH-G, and N3-G were typically preformed at the following 
ratios: 4:1 GSMP:GTP, ~31:1 NH2NH-G:GTP, and 4:1 N3-G:GTP. The supplementation of 
GTP permits the use of modified analog:GTP ratios as high as 50:1. These two adjustments 
to a typical in vitro transcription increase the total RNA yield to levels comparable to those 
from a typical in vitro transcription, while permitting ~90% incorporation of the modified 
guanosine analog at the 5'-end. 
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Chapter 1 
Introduction 
 
1.1 Biological versatility of RNA 
RNA is a macromolecule found in all known forms of life. While RNA initially was 
believed to be a simple information carrier, during the last three decades we have begun 
to appreciate that RNA is active in multiple biological processes, including catalyzing 
reactions, fighting infectious agents, and regulating gene expression (Cech, 2012; 
Guerrier-Takada et al., 1983; Kruger et al., 1982). The biological versatility of RNA has 
elicited interest in making it a target for new drugs and in exploring it as a tool for novel 
therapies (Blakeley et al., 2012). RNAs are linked to various diseases, making it a target 
for small molecules that can modulate function. The different types of biological functions 
of RNA correlate with its structural plasticity. Covalently-attached biochemical or 
biophysical probes (e.g., fluorophores, paramagnetic probes) at specific positions can be 
used to uncover structure-function relationships in target RNAs. Generation of such 
modified RNAs, however, often requires the conjugation of molecular probes to suitable 
chemical functionalities that have been introduced at either terminal or internal positions 
in the target RNA (Pagano et. al., 2011; Paredas et al., 2011; Qin and Pyle, 1999; Zhang et 
al., 2001).  
 
1.2 Methods to label RNA 
Whether it is through enzymatic methods or solid-phase synthesis, there are multiple 
approaches to label an RNA. Each method has its benefits, as well as its own 
 
 
13 
shortcomings. Solid-phase synthesis of RNA allows for direct modification as well as a 
variety of post-synthetic modifications compared to enzymatic methods (Paredas et al., 
2011). Solid-phase synthesis allows for terminal and internal labeling. However, there are 
some limitations when using synthetic RNA to introduce a modification. Foremost, 
modifications need to be incorporated as phosphoramidites at the specified location 
(Paredas et al., 2011; Qin and Pyle, 1999). Another limitation pertains to the length of 
RNA synthesized, typically 40 nucleotides or less (Qin and Pyle, 1999). 
For longer RNAs, post-transcriptional methods or enzymatic routes can be utilized. 
For example, following in vitro transcription, a 3'-terminal modification can be effected 
though periodate oxidation (Qin and Pyle, 1999). Periodate oxidizes the 3'-terminal diol 
to generate a dialdehyde, introducing a chemical functionality that renders it reactive 
towards a variety of compounds including hydrazine derivatives. Enzymatic RNA 
synthesis, similar to solid-phase synthesis, can be used to introduce modifications at 
either terminus or at an internal location, although the latter entails an additional ligation 
step. For example, T4 polynucleotide kinase (T4 PNK), can introduce a 5'-thiol following 
RNA synthesis when it transfers the γ-phosphorothioate of ATPγS to the 5'-hydroxyl of 
the target RNA (Pagano et al., 2011). Introducing this unnatural chemical functionality 
enables reaction with reagents such as 5-iodoacetamidofluorescein (5-IAF; Pagano et al., 
2011).  
It is important to appreciate that there are methods to attach a label on the RNA 
without the need for a modification post-synthesis. Through the use of a DNA template 
with an unnatural base (introduced through solid-phase DNA synthesis), an unnatural 
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base can be introduced during in vitro transcription of an RNA (Domnick et al., 2015; Tor 
and Dervan, 1993). In the recent example cited, the yield of full-length transcripts was 
reported to be low; 36% of the transcripts were full length when using DNA with one 
unnatural base, and 16% when using DNA with two unnatural bases (Domnick et al., 
2015).  Another approach to introduce a label to the RNA is through the hybridization of 
a complementary fluorescent-labeled DNA or PNA oligonucleotide (Schmitz et al., 2014). 
A caveat to this method is that the hybridization might alter the structure and therefore 
the function of the target RNA.  
 
1.3 Statement of the problem 
A simple approach to introduce a new chemical functionality in an RNA is 
accomplished by introducing a 5'-modification through use of a T7 RNA polymerase-based 
in vitro transcriptions (IVTs) of DNA templates. Depending on the promoter used, 
guanosine or adenosine analogs can be used to introduce a 5'-modification (Paredas et 
al., 2011). The polymerase will incorporate a guanosine or adenosine analog at the 
transcriptional initiation site instead of GTP or ATP, illustrating the enzyme’s tolerance for 
incorporating modified nucleotide analogs.  
Although there are multiple approaches to introduce new chemical functionalities 
into an RNA, my study focuses on a 5'-modification introduced during IVTs of DNA 
templates containing a class III ϕ6.5 promoter by T7 RNA polymerase. With this promoter, 
GTP is used preferentially to initiate transcription; therefore, guanosine analogs 
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(nucleoside or nucleotide monophosphate) have been used as transcriptional initiators to 
introduce different reactive groups at the 5'-end of transcribed RNAs.  
The three guanosine analogs used in this study were synthesized by Dr. Edward 
Behrman (OSU): 5'-deoxyguanosine-5'-monophosphorothioate (GSMP), 5'-deoxy-5'-
hydrazinylguanosine (NH2NH-G), and 5'-azido-5'-deoxyguanosine (N3-G) (Figure 1). The 
following reasoning inspired the choice of these three guanosine analogs. GSMP was used 
because a thiol would be generated with an alkaline phosphatase treatment post-
transcription. Thiols react with many compounds, including iodoacetamides, maleimides, 
and bromomethyl ketones, allowing for a wide array of different biochemical or 
biophysical probes to be introduced into the thiol-containing target RNA (Zhang et al., 
2001).  NH2NH-G was studied, because hydrazines are more reactive than amines and will 
react with active esters (e.g., commonly available NHS-esters) and aldehydes (Raddatz et 
al., 2002; Skipsey et al., 2013). N3-G was studied because of the recent wide use of click 
chemistry, one example being the copper(I)-promoted azide-alkyne cycloaddition 
reaction (Paredas and Das, 2011). 
These guanosine analogs can only be used as the initiator nucleotide because they 
cannot promote formation of a phosphodiester bond, a key attribute of elongation 
(Figure 2). During the elongation steps in transcription, the release of pyrophosphate 
from the incoming rNTP provides the driving force for bond formation. Therefore, these 
guanosine analogs compete with GTP only during initiation. Due to this reason, GTP is 
preferentially depleted compared to the guanosine analog.  
 
 
16 
Adding guanosine analogs in a large molar excess over GTP at the start of transcription 
generates transcripts that are predominantly 5'-modified, but the overall yield of RNA is 
greatly compromised (Scheme 1). However, if the guanosine analog and GTP were added 
in equal molar amounts, the overall yield of RNA will be high, but the amount of labeled 
RNA will decrease (Scheme 1). Andrew Wallace, a former undergraduate and 
subsequently a graduate student in the Gopalan laboratory, reported that using 
equimolar amounts of the guanosine analog and GTP in an IVT resulted in only 37% of the 
RNA transcripts being 5'-modified (Wallace, 2013). While a higher amount of guanosine 
analog to GTP might render it more favorable for initiation by T7 RNA polymerase, an 
excess of guanosine analog over GTP would be expected to cause premature termination 
of transcription due to the rapid depletion of GTP. I set out to evaluate a method in which 
neither the overall yield of RNA or the 5'-modified RNA are compromised (Scheme 1). 
 
1.4: Solution to the problem: a phased-addition strategy 
An assay to determine the yield of modified RNA from an in vitro transcription using 
a 4:1 ratio of N3-G:GTP showed that 87% of the transcripts were initiated with N3-G; these 
studies were performed with a tetramer model RNA (Wallace, 2013). While the initial 4:1 
ratio of N3-G:GTP might lead to the expectation that only 80% of the transcripts should 
be modified, it is in fact not the case due to the rapid depletion of GTP. As GTP is 
consumed during an IVT, the guanosine analog:GTP ratio is probably  
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greater than 4:1. The idea that the ratio is not constant between the guanosine analog 
and GTP during in vitro transcription is the basis for the phased-addition strategy, which 
was developed to ensure that neither the total yield nor the yield of modified RNA is 
compromised during transcription.  
The phased-addition strategy differs from a normal transcription in two ways. The first 
is through the introduction of a supplementation approach (Figure 3). During the 
transcription, the reaction is supplemented with defined amounts of GTP. 
Supplementation with GTP allows full-length transcripts to still be made during multiple 
sequential rounds of IVT, even while ensuring that GTP will not out-compete the 
Scheme 1: Two different scenarios are depicted to illustrate the problem of concomitantly achieving 
high 5'-modification and high RNA yield during in vitro transcription. (Top) A high concentration of the 
guanosine analog leads to a high yield of modified RNA but low total RNA yield. (Middle) However, 
equal concentration of the guanosine analog and GTP leads to low 5'-modification but high total RNA 
yield. (Bottom) The overall goal of this research is to design a method that will lead to mostly modified 
RNA at high RNA yield.  
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guanosine analog at initiation. Due to the supplementation approach, I was able to 
implement the second component of the phased-addition strategy. Since rapid depletion 
of GTP is no longer a concern, the initial guanosine analog:GTP ratio could be increased 
to levels never tested before.  
I investigated and validated a phased-addition strategy that results in high yields of 
full-length, 5'-modified RNAs from small-scale transcriptions and used evidence from 
spectrophotometric assays to accurately calculate of the incorporation efficiency of each 
guanosine analog. Results from experiments with three guanosine analogs (GSMP, 
NH2NH-G, and N3-G) demonstrate that the phased-addition strategy enhances the yield 
of RNA obtained by in vitro transcription while improving the extent of modification. 
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Figure 1. Synthesis of three guanosine analogs from 5'-iodo-5'-deoxyguanosine. 
Synthesis of 5'-deoxyguanosine-5'-monophosphorothioate, 5'-deoxy-5'-hydrazinyl 
guanosine, and 5'-azido-5'deoxyguanosine is depicted.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I2 
P(Ph)3 
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Figure 2. Phosphodiester bond formation during RNA elongation by an RNA 
polymerase. Release of pyrophosphate provides the energy to allow incorporation of the 
incoming nucleotide into the growing RNA chain. 
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Figure 3. Phased-addition strategy. This strategy entails the addition of GTP every 30 min 
for the first three or four h of a modified in vitro transcription. The fixed-ratio approach 
where the initial guanosine analog:GTP ratio is held constant has been typically used for 
modified in vitro transcription. The supplementation approach allows for an increase in 
the initial guanosine analog:GTP ratio without concerns about the rapid depletion of GTP 
during elongation. 
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Chapter 2 
Materials and Methods 
 
2.1 Preparation of DNA template 
For all the studies reported here, an Arabidopsis thaliana pre-tRNACys (149 nt) was 
used as the model. This pre-tRNA was transcribed using a template generated by PCR. 
The PCR amplification employed Q5® polymerase (New England BioLabs® Inc.), the 
universal forward primer (5'-CGACGTTGTAAAACGACGGCCAG-3'), the universal reverse 
primer (5'-GGAAACAGCTATGACCATGAT-3'), and pBT7-pre-tRNACys as the template.  
 
2.2: Standard in vitro transcription 
 pre-tRNACys was generated through a run-off in vitro transcription of PCR-
generated linear templates (as described above). The reactions were preformed for 16 h 
at 37°C in 80 mM HEPES (pH 7.5), 33 mM MgCl2, 1 mM spermidine, 10 mM dithiothreitol, 
6 mM rNTPs (ATP, CTP, GTP, UTP), and in-house purified T7 RNA polymerase. The RNA 
was purified by sequential DNase I treatment at 37°C for 1 h, phenol-chloroform 
extraction, dialysis to remove unincorporated rNTPs, and ethanol precipitation. This 
purification method was employed for all RNAs used in this study. The yield of RNA was 
determined by measuring the absorbance at 260 nm. 
 
2.3 Incorporation of 5'-deoxyguanosine-5'-monophosphorothioate, 5'-deoxy-5'-
hydrazinylguanosine, 5'-azido-5'-deoxyguanosine into pre-tRNACys 
 
 pre-tRNACys was generated through a run-off in vitro transcription as described 
above with one key modification. While ATP, CTP, and UTP were 6 mM, the modified 
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guanosine analog and GTP were used at ratios specified in the text. For the phased-
addition strategy, either 0.5 mM or 1 mM GTP (as specified) was added every 30 min for 
three or four h (Figure 4). The RNA was purified and the yield quantitated in an identical 
fashion to the standard transcriptions.  
 Following transcription with GSMP, the RNA transcripts were subjected to 
treatment with calf intestinal phosphatase (0.5 units/μg RNA) at 37°C for one h. The RNA 
was purified by phenol-chloroform extraction and ethanol precipitation. The resulting 
RNA should have a 5'-thiol if the transcript was indeed initiated with GSMP.  
 
2.4 Quantitation of 5'-sulfhydryl incorporation in an RNA 
Ellman’s test was used to determine the amount of 5'-thiol in the RNA (Ellman, 
1959). Ellman’s reagent [5,5'-dithio-bis-(2-nitrobenzoic acid)] was mixed with known 
concentrations of L-cysteine (0.05, 0.10, 0.15, 0.20, 0.25, 0.30, 0.35, 0.40, 0.45, 0.50, 0.55 
or 0.60 mM) in 0.1 M sodium phosphate (pH 8), 1 mM EDTA and incubated for 15 min at 
~24°C. A NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientific) was then used to 
measure the absorbance at 412 nm, and generate a standard curve.  By using this 
reference plot, the amount of 5'-thiol incorporation in any RNA could be determined.   
 
2.5 Quantitation of 5'-hydrazinyl incorporation in an RNA 
 To quantitate the amount of transcripts initiated with NH2NH-G, I adopted a 
spectrophotometric test typically used to measure the amount of hydrazine in the air 
(Kaveeshwar and Gupta, 1992). NH2NH-G was standardized through a potassium 
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permanganate titration, and then known concentrations of NH2NH-G (0.006, 0.012, 
0.019, 0.024, 0.028, 0.033, 0.038, 0.043, 0.047 or 0.052 mM) were reacted with 
veratraldehyde [2% (v/v) in 25% (v/v) ethanol] at 55°C for one h. The resulting mixture 
was then treated with 2.5 M sulfuric acid and the absorbance of the hydrazone product 
was measured at 410 nm using a NanoDrop 2000 UV-Vis Spectrophotometer. A linear 
colorimetric plot was established and used to quantitate the incorporation of NH2NH-G 
in an RNA. 
 
2.6 Quantitation of 5'-azido incorporation in an RNA 
To quantitate the amount of transcripts initiated with N3-G, I adopted a 
spectrophotometric test typically used to measure the amount of azide in the air or soda 
(Christova-Bagdassarian and Atanassova, 2007; Tsuge et al., 2001). Known concentrations 
of N3-G (0.03, 0.06, 0.15, 0.30, 0.45, 0.60, 0.75, 0.91, 1.06, 1.21, 1.36, 1.51 or 1.66 mM) 
were reacted with 4 M hydrochloric acid and 0.6 M ferric chloride. The reactions were 
mixed at ~24°C and the absorbance of the ferric azide complex could be immediately 
measured at 460 nm using a NanoDrop 2000 UV-Vis Spectrophotometer. Using this 
colorimetric plot, the incorporation of N3-G in any RNA could be quantitated. 
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2.7 Determination of the extinction coefficient for 5'-deoxyguanosine-5'-
monophosphorothioate, 5'-deoxy-5'-hydrazinylguanosine, 5'-azido-5'- 
deoxyguanosine. 
 
 To determine the extinction coefficient of each guanosine analog, known 
concentrations of each guanosine analog were made (25, 50, 75, and 100 μM) in 
phosphate buffer (pH 7). The absorbance was then measured at 251 nm, which is the 
maximum wavelength for absorbance for guanosine. The absorbance values were plotted 
against the concentration, and each extinction coefficient was determined from the slope 
of the linear plot generated.  
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Figure 4. Phased-addition strategy to enhance initiation with GSMP, NH2NH-G, and N3-G during an IVT.
 
 
27 
Chapter 3 
Results 
 
 
3.1 Extinction coefficient of 5'-deoxyguanosine-5'-monophosphorothioate, 5'-deoxy-
5'-hydrazinylguanosine, 5'-azido-5'-deoxyguanosine 
 
 The extinction coefficient of each guanosine analog was determined. For GSMP, 
NH2NH-G, and N3-G, the extinction coefficients were determined to be 13,693, 13,208, 
and 13,145 M-1 cm-1, respectively (Figure 5). These values are comparable to that reported 
for guanosine 5'-monophosphate (13,650 M-1 cm-1; Behrman, 2000).  
 
3.2 Incorporation of 5'-deoxyguanosine-5'-monophosphorothioate 
5'-Deoxyguanosine-5'-monophosphorothioate was synthesized by reacting 5'-
iodo-5'-deoxyguanosine with thiophosphate in sodium hydroxide. Selective precipitation 
using methanol yielded GSMP of ~65% purity (Brear et al., 2007). 
There are reports of successful incorporation of GSMP in IVTs of short RNAs using 
T7 RNA polymerase and a 4:1 GSMP:GTP ratio. For example, Zhang et al. (2001) reported 
60% 5'-incorporation, which was determined by reacting the thiol with biotin-HPDP. The 
transcripts with a 5'-thiol were biotinylated with the biotin-HPDP and subsequently could 
be detected as band-shifts through the use of a streptavidin-based gel-shift assay. By 
using a phosphorimager, the fraction of the RNA with a 5'-modification relative to the 
total RNA was quantitated by analyzing the intensity of the individual bands in the gel-
shift assay (Zhang et al., 2000). In my studies, using a 4:1 GSMP:GTP ratio, the RNA yield 
was 67 ± 14 μg from a 100 μL IVT and 82 ± 1% of the transcripts had been initiated with 
GSMP (Figure 6). The incorporation of GSMP was determined through the use of Ellman’s 
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test, which is typically used for quantitation of protein thiols (Ellman, 1959) (Figure 7). In 
a typical in vitro transcription, where there is no modified guanosine analog, the yield was 
137 ± 8 μg from a 100 μL IVT, whereas the yield from a transcription using 4:1 GSMP:GTP 
ratio was only 67 μg from a 100 μL IVT (Figure 6). Each set of results was obtained from 
three independent trials.  
To evaluate the phased-addition strategy, my initial tests were performed using a 
11:1 GSMP:GTP ratio with subsequent additions of 0.5 mM GTP every 30 min for the first 
three h of the IVT. I determined from three independent trials that the yield was 104 ± 2 
μg from a 100 μL IVT, representing a 1.5-fold increase from the 67 μg obtained using a 4:1 
GSMP:GTP ratio IVT (Figure 6). Additionally, the incorporation of 5'-thiol was found to be 
91 ± 1% (Figure 6). However, to conclusively prove that the phased-addition approach led 
to these remarkable gains, I performed three independent in vitro transcriptions using a 
11:1 GSMP:GTP ratio, but without any supplementation of GTP during the IVT. Using this 
approach, the total yield of RNA was 23 ± 3 μg from a 100 μL IVT, with 92 ± 0.5% of the 
transcripts being initiated with GSMP (Figure 6). 
To ensure that the supplementation of GTP for only the first three hours was 
sufficient, I extended the phased-addition to four hours. A single trial revealed that the 
yield was 107 μg from a 100 μL IVT, confirming that RNA yield (107 versus 104 μg) does 
not change significantly by extending the supplementation from three to four hours. 
While these results were an improvement over those reported (Zhang et al., 2000; 
Zhang et al., 2001), I sought to determine if further changes to the initial GSMP:GTP ratio 
might afford additional gains. I increased the GSMP:GTP ratio to 37:1, and increased the 
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GTP supplementation from 0.5 mM to 1 mM every 30 min for three h. The RNA yield 
increased to 122 ± 2 μg from a 100 μL IVT and 5'-thiol incorporation was 90 ± 1% (Figure 
6). With these new conditions, the yield increased 2-fold compared to the fixed-ratio 
approach using a 4:1 GSMP:GTP ratio. 
 
3.3 Incorporation of 5'-deoxy-5'-hydrazinylguanosine 
5'-Deoxy-5'-hydrazinylguanosine was synthesized by reacting 5'-iodo-5'-
deoxyguanosine with hydrazine. The resulting compound was purified by precipitation 
with methanol and recrystallization from methanol (Brear et al., 2007). 1H NMR spectrum 
of NH2NH-G indicates that the purity is ~80%  (Figure 8). 
Successful incorporation of NH2NH-G in an RNA generated by T7 RNA polymerase 
has been reported (Skipsey et al., 2013). In this previous study, a 31.3:1 NH2NH-G:GTP 
ratio was employed. Approximately 30-40% incorporation of NH2NH-G was estimated 
although with a low yield (numbers not reported, however). The incorporation of NH2NH-
G was estimated by measuring the amount of fluorescence after reacting the NH2NH-G-
containing RNA with fluorescien isothiocyanate.  
For a direct measure of the incorporation of NH2NH-G during an in vitro 
transcription, I sought a spectrophotometric assay that would measure the amount of 
hydrazine for NH2NH-G either free or incorporated in an RNA. Although I did not find 
reports of such an assay, a spectrophotometric test for determining hydrazine in the air 
based on a reaction with veratraldehyde has been documented (Kaveeshwar and Gupta, 
1992). I adopted this assay for my objective. I used NH2NH-G and first established a linear 
 
 
30 
colorimetric response (Figure 9). With this standard reference curve in hand, I could 
determine the amount of NH2NH-G incorporated in an RNA.  
Consistent with the findings of Skipsey et al. (2013), a 31:1 NH2NH-G:GTP ratio 
resulted in a yield of 10 μg of pre-tRNACys from a 100 μL IVT and 37% of the transcripts 
were initiated with NH2NH-G (Figure 10). However, when I used an initial 11:1 NH2NH-
G:GTP ratio coupled with additions of 0.5 mM GTP every 30 min for three h, the RNA yield 
increased to 78 ± 3 μg from a 100 μL IVT. The NH2NH-G incorporation was determined to 
be 26% (Figure 10).  
To increase the extent of incorporation of NH2NH-G, the NH2NH-G:GTP ratio was 
increased to 22:1 with additions of 0.5 mM GTP every 30 min for three h. Although the 
yield of RNA decreased from 78 μg to 44 μg, the NH2NH-G incorporation increased from 
26% to 42%. In fact, with a 37:1 NH2NH-G:GTP ratio, coupled with additions of 1 mM GTP 
every 30 min for the first three hours of transcription, the RNA yield improved further to 
104 μg from a 100 μL IVT with 55% of the transcripts being initiated with NH2NH-G (Figure 
10).  
Further investigation with a 40:1 NH2NH-G:GTP or a 50:1 NH2NH-G:GTP ratio 
coupled with 1 mM GTP addition every 30 min for four h showed further improvements 
with respect to both RNA yield and incorporation of NH2NH-G. The 40:1 NH2NH-G:GTP 
ratio resulted in 116 μg of pre-tRNACys from a 100 μL IVT with 58% NH2NH-G 
incorporation, and the 50:1 NH2NH-G:GTP ratio generated  105 μg with 62% incorporation 
(Figure 10). These results are from a single trial, and need to be repeated. 
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3.4 Incorporation of 5'-azido-5'-deoxyguanosine 
5'-Azido-5'-deoxyguanosine was synthesized by reacting 5'-iodo-5'-
deoxyguanosine with sodium azide. The resulting compound was purified through 
crystallization by cooling the reaction mixture (Brear et al., 2007).  
There are reports of successful incorporation of N3-G using in vitro transcriptions 
with T7 RNA polymerase and a 4:1 ratio of N3-G:GTP. For example, Paredas et al. (2011) 
determined that a 4:1 N3-G:GTP ratio results in almost complete modification at the 5'-
end. The incorporation extent was determined by assessing a copper (I) mediated click 
ligation between an RNA with a 3'-alkyne functional group and an RNA with a 5'-azido 
group. Following ligation, ethidium bromide staining of a polyacrylamide gel was used to 
determine the extent of unreacted transcripts. Paredas et al. (2011) concluded that N3-G 
almost completely replaces GTP at the initiation site due to the low number of unreacted 
transcripts, although quantitation was not provided (Paredas et al., 2011). My studies 
showed that a 4:1 N3-G:GTP ratio resulted in a yield of 69 ± 8 μg of pre-tRNACys from a 100 
μL IVT with 84 ± 0.4% of the transcripts being initiated with N3-G (Figure 11).  
The incorporation of N3-G was determined through a spectrophotometric test, 
adopted from an assay used to measure free azide in the air and in soda (Christova-
Bagdassarian and Atanassova, 2007; Tsuge et al., 2001). The assay is based on the 
production of a ferric-azide chromophore resulting from the reaction of free azide with 
ferric chloride  (Figure 12a). Although this was not an assay developed for determination 
of N3-G, either free or incorporated into an RNA, the use of N3-G instead of free azide 
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revealed a linear colorimetric response (Figure 12b). With this standard reference curve 
in hand, I could determine the amount of N3-G incorporated in an RNA.  
To improve the extent of incorporation of N3-G, I preformed an in vitro 
transcription at a 37:1 N3-G:GTP and added 1 mM GTP every 30 min for the first three h 
of transcription. The pre-tRNACys yield was 116 ± 2 μg from a 100 μL IVT with 92 ± 2% of 
the transcripts initiated by N3-G (Figure 11). These results represent a 1.7-fold increase in 
the RNA yield compared to a typical 4:1 N3-G:GTP ratio. 
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Figure 5: Extinction coefficients of GSMP, NH2NH-G, and N3-G. 
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Figure 6. IVT using GSMP as the transcriptional initiator: results from the fixed-ratio and 
phased-addition approaches. The blue bars represent the yield of RNA in μg from a 100 
μL IVT and the purple bars represent the percent of transcripts with a 5'-sulfhydryl 
substitution. 
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Figure 7. Quantitation of 5'-sulfhydryl incorporation in an RNA. (a) Ellman’s test: 
reaction of DTNB [5,5'-dithio-bis-(2-nitrobenzoic acid)] with a free thiol produces TNB2- 
(2-nitro-5-thiobenzoic acid), which absorbs light at 412 nm. (b) Linear colorimetric 
standard curve with L-cysteine. 
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Figure 8. (a) 1H NMR of NH2NH-G. (b) Magnification of the spectrum from 3.8 to 4.6 ppm 
to highlight peaks corresponding to contaminants in the NH2NH-G preparation. 
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Figure 9. Quantitation of 5'-hydrazinyl incorporation in an RNA. (a) Reaction of 
veratraldehyde with a hydrazine to produce a hydrazone derivative that absorbs light at 
410 nm. (b) Linear colorimetric standard curve with NH2NH-G. 
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Figure 10. IVT using NH2NH-G as the transcriptional initiator: results from fixed-ratio 
and phased-addition approaches. The blue bars represent the yield of RNA in μg from a 
100 μL IVT and the purple bars represent the percent of transcripts with a 5'-hydrazinyl 
substitution.   
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Figure 11. IVT using N3-G as the transcriptional initiator: results from fixed-ratio and 
phased-addition approaches. The blue bars represent the yield of RNA in μg from a 100 
μL IVT and the purple bars represent the percent of transcripts with a 5'-azido 
substitution.  
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Figure 12. Quantitation of 5'-azido incorporation in an RNA. (a) Reaction of ferric 
chloride with an azide to produce a ferric azide complex that absorbs light at 460 nm. (b) 
Linear colorimetric standard curve with N3-G. 
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Chapter 4 
Discussion 
 
4.1 Incorporation of 5'-deoxyguanosine-5'-monophosphorothioate and 5'-azido-5'-
deoxyguanosine 
 
It is vital to determine the amount of RNA modified with the guanosine analogs, 
because it provides the maximum amount of RNA that can be further labeled with a 
biochemical or biophysical probe. The extent of 5'-incorporation of all guanosine analogs 
was determined through incorporation spectrophotometric assays, resulting in a firm 
estimate of the amount of 5'-modified pre-tRNACys. 
I was able to incorporate GSMP at the 5'-terminus of pre-tRNACys by using the 
phased-addition strategy in a run-off IVT using T7 RNA polymerase to generate 122 μg 
from a 100 μL IVT with 90% of the transcripts initiated with GSMP, as determined using 
the Ellman’s test (Ellman, 1959). Similarly, I was able to incorporate N3-G at the 5'-
terminus of pre-tRNACys by using the phased-addition strategy in a run-off IVT using T7 
RNA polymerase to generate 116 μg in a 100 μL IVT with 92% of the transcripts initiated 
by N3-G determined by use of the ferric chloride test (Christova-Bagdassarian and 
Atanassova, 2007; Tsuge et al., 2001).  
In comparison to a typical IVT, I determined that there is a 2-fold (~52%) decrease 
in the yield of RNA when a 4:1 GSMP:GTP ratio is utilized. Additionally, I confirmed that 
by increasing the GSMP:GTP ratio, the GSMP could out-compete GTP at initiation and 
used predominantly for initiation (~92% of the transcripts). The phased-addition strategy 
also improved the yield such that there is only 11% decrease compared to a standard 
transcription. In the case of N3-G, using 4:1 N3-G:GTP ratio results in a 50% decrease in 
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RNA yield relative to the standard IVT; however, using the phased-addition strategy 
results in only a 16% decrease from a standard transcription. While tweaking the 
GSMP:GTP or N3-G:GTP ratio and changing the number of GTP supplements might yield 
additional improvements, the results reported here already confirm that we can obtain 
90% 5'-incorporation of the modified guanosine analog at ~90% of the typical IVT yield. 
 
4.2 Incorporation of 5'-deoxy-5'-hydrazinylguanosine 
 I was able to incorporate NH2NH-G at the 5'-terminus of pre-tRNACys by using the 
phased-addition strategy in a run-off IVT using T7 RNA polymerase to generate 105 μg 
from a 100 μL IVT with 62 % incorporation of NH2NH-G, as determined using the 
veratraldehyde test (Kaveeshwar and Gupta, 1992). With use of the phased-addition 
strategy, I was able to improve the RNA yield by 11-fold compared to the fixed-ratio 
approach. Additionally the incorporation increased from 37% to 62%. 
 The NH2NH-G incorporation results highlight an interesting dilemma, since T7 RNA 
polymerase does not appear to favor NH2NH-G over GTP. When I increased the ratio 
between NH2NH-G and GTP, such that there was a high concentration (22 mM) of NH2NH-
G and only 0.5 mM of GTP, the incorporation was still low. However, when the ratio 
between NH2NH-G and GTP was increased, while lowering the concentrations of NH2NH-
G and GTP, I determined that there was higher incorporation of NH2NH-G. Clearly, a 
higher concentration of NH2NH-G has an inhibitory effect, and results in a lower yield. 
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 Again, while the results are promising, there is always room for fine-tuning the 
ratio between NH2NH-G and GTP, as well as the amount of GTP added during transcription 
or the number of times GTP is added during an IVT.  
 
4.3 Conclusions 
 
The results from all three guanosine analogs show that the phased-addition 
strategy enhances the yield of RNAs obtained through IVT, while ensuring that the vast 
majority of transcripts are initiated with the guanosine analog and not GTP. Central to 
these findings was also the ability to use two spectrophotometric assays to determine the 
amount of 5'-hydrazinyl and 5'-azido-modified RNAs.  
The use of dinucleotides with a 5'-modification (e.g., 5'-azido-GpG) is a possible 
solution to the low yield problem encountered with the fixed-ratio approach. However, 
the dinucleotides are rather expensive, ranging between around $320 and $750 for a 1 
μmole scale synthesis (Bio-Synthesis, Inc.). Due to the cost, the phased-addition strategy 
is favorable because it employs affordable and easily prepared reagents. 
The phased-addition strategy, demonstrated here for 5'-labeling, could also be 
implemented to produce an internal modification by exploiting the DNA splint-based RNA 
ligation method (Moore and Sharp, 1992). Consider an RNA of 100 nucleotides in which 
modification is desired at position 66. Two different in vitro transcriptions can be 
preformed to generate two RNAs corresponding to positions 1 – 65 and 66 – 100. The 
shorter RNA (66 – 100, 35 nt) could be initiated using a 2’-modified guanosine 5’-
monophosphate (or adenosine 5’-monophosphate, depending on the promoter of T7 
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RNA polymerase). The transcription with the modified guanosine 5’-monophosphate 
could be carried out using the phased-addition strategy, which will insert the 2'-modifed 
guanosine at the 5'-terminus of the transcript. The 5'-phosphate of this shorter transcript 
could then be ligated to the longer RNA (1 – 65, 65 nt) using a DNA splint and DNA ligase 
(Figure 13).  
The first step in site-specific modification of RNAs is to generate RNAs with the 
appropriate reactive handles and in large amounts. The phased-addition strategy helps 
fulfill this objective. An important future direction will be to validate the phased-addition 
strategy with different RNAs of varying compositional bias and for internal labeling.  
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Figure 13. Application of the phased-addition strategy for introducing an internal 
modification. While the DNA splint-based RNA ligation approach of Moore and Sharp 
(1992) is key to generating the desired RNA with an internal site-specific modification, the 
phased-addition strategy could enhance the overall yield by ensuring that the 3’-fragment 
is predominantly 5’-modified. 
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methods for the preparation of 5'-substituted guanosine derivatives. Chem. 
Comm. 33: 4980-4981.  
 
Cech TR (2012) The RNA worlds in context. Cold Spring Harb. Perspect. Biol. 4: 
a006742. 
 
Christova-Bagdassarian V, Atanassova M (2007) Spectrophotometric 
determination of sodium azide in workplace air. J. Univ. Chem. Technol. 
Metallurgy 42: 311-314. 
 
 
 
47 
Domick C, Eggert F, Kath-Schorr S (2015) Site-specific enzymatic introduction of a 
norbornene modified unnatural base into RNA and application in post-
transcriptional labeling. Chem. Commun. DOI: 10.1039/C5CC01765C 
 
Ellman GL (1959) Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82: 70-77. 
 
  
  
Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S (1983) The RNA 
moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35: 849–857. 
 
Kaveeshwar R, Gupta VK (1992) A new spectrophotometric method for the 
determination of hydrazine in environmental samples. Anal. Chem. 344: 114-
117. 
 
Kruger K, Grabowski PJ, Zaug AJ, Sands J, Gottschiling DE, Cech TR (1982) Self-
splicing RNA: autoexcision and autocyclization of ribosomal RNA intervening 
sequence of Tetrahymena. Cell 31: 147-157. 
 
Naga Prashant K, Anupama S (2014) Synthesis and biological evaluation of some 
novel Schiff’s bases of veratraldehyde. Asian J. Pharm. Clin. Res. 2: 65-68. 
 
Pagano JM, Clingman CC, Ryder SP (2011) Quantitative approaches to monitor 
protein-nucleic acid interactions using fluorescent probes. RNA 17: 14-20. 
 
 
48 
 
Paredas E, Das SR (2011) Click chemistry for rapid labeling and ligation of RNA. 
Chem. Biochem. 12: 125-131. 
 
Paredas E, Evans M, Das SR (2011) RNA labeling, conjugation and ligation. 
Methods 54: 251-259. 
 
Qin PZ, Pyle AM (1999) Site-specific labeling of RNA with fluorophores and other 
structural probes. Methods 18: 60-70. 
 
Raddatz S, Mueller-Ibeler J, Kluge J, WäΒ L, Burdinski G, Haven JR, Onofrey TJ, 
Wang D, Schweitzer M (2002) Hydrazide oligonucleotides: new chemical 
modification for chip array attachment and conjugation. Nucleic Acids Res. 30: 
4793-4802. 
 
Royer CA, Scarlata SF (2008) Fluorescence approaches to quantifying 
biomolecular interactions. Methods Enzymol. 450: 79-106. 
 
Schmitz AG, Zelger-Paulus S, Gasser G, Sigel RKO (2014) Internal labeling strategy 
of large RNAs with minimal perturbation using fluorescent PNA. ChemBioChem. 
DOI: 10.1002/cbic.201500180 
 
 
 
49 
 
Skipsey M, Hack G, Hooper TA, Shankey MC, Conway LP, Schröder M, Hodgson 
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